Organization | March of Dimes

March of Dimes Report issue

Foundation Phase 2 Phase 4

Founded: Arlington VA United States (1938)

Organization Overview

First Clinical Trial

2002

NCT00146302

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2020

Timeline

NOW

Now

Alternative names

March of Dimes

Active Ingredients

Drugs in Phase 4 Trials (4)

amino acids (Freamine) (1 trial)

bacille calmette-guerin (2 trials)

icosapent ethyl (vascepa) (1 trial)

vitamin a (1 trial)

Drugs in Phase 2 Trials (2)

acetylcysteine (mucomyst) (1 trial)

acetylsalicylic acid (aspirin) (1 trial)

Drugs in Other Trials (1)

bivalent oral polio vaccine (bopv), type 1 and type 3 (BOPV) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Birth Weight (Phase 4)

Homocystinuria (Phase 2)

Infant Death (Phase 4)

Pre-Eclampsia (Phase 2)

Premature Birth (Phase 4)

Tuberculosis (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 6
# of Trial APIs: 7